Back
Syndax Pharmaceuticals Vs. Arvinas Industry Stock Comparison
Sell
40
SNDX
Syndax Pharmaceuticals
Last Price:
18.61
Seasonality Move:
-8.74%
Sell
38
ARVN
Arvinas
Last Price:
25.61
Seasonality Move:
12.72%
Sell
40
Syndax Pharmaceuticals (SNDX)
is a Sell
Is Syndax Pharmaceuticals a Buy, Sell or Hold?
- The current Syndax Pharmaceuticals [SNDX] share price is $18.00. The Score for SNDX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- SNDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Arvinas (ARVN)
is a Sell
Is Arvinas a Buy, Sell or Hold?
- The current Arvinas [ARVN] share price is $24.97. The Score for ARVN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ARVN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNDX Stock Price Chart
What is Syndax Pharmaceuticals's stock price today?
-
The Syndax Pharmaceuticals share price today is $18.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNDX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARVN Stock Price Chart
SNDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.72 | Sell |
| Relative Strength Index (14 RSI): | 34.73 | Sell |
| Chaikin Money Flow: | 979477 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.68 - 20.6) | Sell |
| Bollinger Bands (100): | (19.2 - 22.34) | Sell |
ARVN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 46.41 | Sell |
| Chaikin Money Flow: | -558867 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.62 - 25.9) | Sell |
| Bollinger Bands (100): | (24.61 - 31.35) | Sell |
SNDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.41 | Sell |
| 20-day SMA: | 19.53 | Sell |
| 50-day SMA: | 20.96 | Sell |
| 200-day SMA: | 21.18 | Sell |
| 8-day EMA: | 18.5 | Sell |
| 20-day EMA: | 19.24 | Sell |
| 50-day EMA: | 20.14 | Sell |
| 200-day EMA: | 20.58 | Sell |
ARVN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.06 | Sell |
| 20-day SMA: | 25.34 | Sell |
| 50-day SMA: | 26.43 | Sell |
| 200-day SMA: | 34.2 | Sell |
| 8-day EMA: | 25.09 | Sell |
| 20-day EMA: | 25.28 | Sell |
| 50-day EMA: | 26.22 | Sell |
| 200-day EMA: | 30.16 | Sell |
Syndax Pharmaceuticals Earnings Growth & SNDX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.34 per share, an increase next quarter of $0.24 per share, a decrease this year of $0.79 per share, and an increase next year of $0.54 per share.
Arvinas Earnings Growth & ARVN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.65 per share, an increase this year of $1.66 per share, and a decrease next year of $1.40 per share.
Syndax Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arvinas Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||